AXSM - 3 Stocks Savvy Investors Are Buying Hand Over Fist
The market looks scary this year, with the S&P 500 down 22%. Moreover, even the healthcare and biotech sectors -- considered defensive sectors in the equity markets -- have taken a beating. While the SPDR S&P Healthcare ETF is down 10% year to date, the SPDR S&P Biotech ETF has plummeted 29%. But there are still some stocks that are defying the bear market exceptionally.
Investors should always keep the long-term potential of businesses in mind when investing in the stock market. Despite worsening economic conditions, demand for quality healthcare and drugs will never truly decline. And biotech companies have positioned themselves well to meet that demand. Here are some reasons why adding these three high-growth stocks to your portfolio could reward you in the long run.
Axsome Therapeutics (NASDAQ: AXSM) has garnered a lot of attention so far this year amid expectations that sales of its two new drugs will soar in the years to come.
For further details see:
3 Stocks Savvy Investors Are Buying Hand Over Fist